NO20065485L - Kjemiske forbindelser - Google Patents
Kjemiske forbindelserInfo
- Publication number
- NO20065485L NO20065485L NO20065485A NO20065485A NO20065485L NO 20065485 L NO20065485 L NO 20065485L NO 20065485 A NO20065485 A NO 20065485A NO 20065485 A NO20065485 A NO 20065485A NO 20065485 L NO20065485 L NO 20065485L
- Authority
- NO
- Norway
- Prior art keywords
- chemical connections
- smilagenin
- connections
- chemical
- hydrated
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Diabetes (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Rheumatology (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
Abstract
Oppfinnelsen tilveiebringer smilagenin i nye amorfe, krystallinske, hydratiserte og solvaterte former, og anvendelsen derav ved fremstilling av farmasøytisk eller spiselig smilagenin og dets derivater.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0409567.5A GB0409567D0 (en) | 2004-04-28 | 2004-04-28 | Chemical compounds |
PCT/GB2005/001635 WO2005105825A2 (en) | 2004-04-28 | 2005-04-28 | Crystalline and amorphous forms of smilagenin |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20065485L true NO20065485L (no) | 2007-01-29 |
Family
ID=32408243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20065485A NO20065485L (no) | 2004-04-28 | 2006-11-28 | Kjemiske forbindelser |
Country Status (17)
Country | Link |
---|---|
US (2) | US20080004249A1 (no) |
EP (2) | EP2402362A2 (no) |
JP (1) | JP2007534736A (no) |
KR (1) | KR20070028387A (no) |
CN (2) | CN102516352A (no) |
AU (1) | AU2005238274A1 (no) |
BR (1) | BRPI0510458A (no) |
CA (1) | CA2564368A1 (no) |
GB (1) | GB0409567D0 (no) |
IL (1) | IL178870A0 (no) |
MX (1) | MXPA06012641A (no) |
NO (1) | NO20065485L (no) |
RU (1) | RU2006141389A (no) |
SG (1) | SG155165A1 (no) |
TW (1) | TW200538145A (no) |
WO (1) | WO2005105825A2 (no) |
ZA (1) | ZA200609596B (no) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2011007842A (es) | 2009-01-24 | 2012-01-12 | Phytopharm Plc | Tratamiento de trastornos mediados por factores neurotroficos. |
US20130210786A1 (en) | 2010-07-20 | 2013-08-15 | Patrick Alexander Howson | Treatment of l-dopa, dopamine agonist and/or dopamine enhancer induced disorders |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL292786A (no) * | 1962-05-15 | |||
US3169959A (en) * | 1963-07-23 | 1965-02-16 | Intermediates Inc | Method of obtaining smilagenin |
CA985172A (en) | 1972-10-06 | 1976-03-09 | Dushan M. Dvornik | Compositions and methods for reducing blood cholesterol |
US4602003A (en) * | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
US4680289A (en) | 1985-06-05 | 1987-07-14 | Progenics, Inc. | Treatment of obesity and diabetes using sapogenins |
US5017562A (en) * | 1987-02-11 | 1991-05-21 | Regents Of The University Of Minnesota | Crystalline saponin-containing complex |
KR20070117001A (ko) * | 1998-03-26 | 2007-12-11 | 파이토팜 피엘씨 | 알츠하이머병을 치료하기 위한 스밀라게닌 및안주로게닌-d |
GB9923076D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB9905275D0 (en) | 1999-03-08 | 1999-04-28 | Phytopharm Ltd | Treatment of conditions associated with membrane-bound receptors and their function |
GB9923078D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB9923077D0 (en) | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
GB0000228D0 (en) | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
AT409100B (de) | 2000-07-24 | 2002-05-27 | Evg Entwicklung Verwert Ges | Vorrichtung zum schweissen einer drahtgittermatte |
GB0107822D0 (en) | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
KR20100093621A (ko) | 2002-03-27 | 2010-08-25 | 파이토팜 피엘씨 | 사포게닌 및 그 유도체의 치료 방법 및 용도 |
US7718792B2 (en) | 2002-10-28 | 2010-05-18 | Phytopharm Plc | Stereospecific reduction of sapogen-3-ones |
-
2004
- 2004-04-28 GB GBGB0409567.5A patent/GB0409567D0/en not_active Ceased
-
2005
- 2005-04-28 EP EP11155898A patent/EP2402362A2/en not_active Withdrawn
- 2005-04-28 SG SG200905023-8A patent/SG155165A1/en unknown
- 2005-04-28 AU AU2005238274A patent/AU2005238274A1/en not_active Abandoned
- 2005-04-28 CN CN2011103029008A patent/CN102516352A/zh active Pending
- 2005-04-28 BR BRPI0510458-0A patent/BRPI0510458A/pt not_active IP Right Cessation
- 2005-04-28 JP JP2007510116A patent/JP2007534736A/ja active Pending
- 2005-04-28 US US11/587,738 patent/US20080004249A1/en not_active Abandoned
- 2005-04-28 CN CNA2005800133676A patent/CN101076539A/zh active Pending
- 2005-04-28 KR KR1020067024949A patent/KR20070028387A/ko not_active Application Discontinuation
- 2005-04-28 WO PCT/GB2005/001635 patent/WO2005105825A2/en active Application Filing
- 2005-04-28 TW TW094113668A patent/TW200538145A/zh unknown
- 2005-04-28 RU RU2006141389/04A patent/RU2006141389A/ru not_active Application Discontinuation
- 2005-04-28 EP EP05738225A patent/EP1742960A2/en not_active Withdrawn
- 2005-04-28 MX MXPA06012641A patent/MXPA06012641A/es unknown
- 2005-04-28 CA CA002564368A patent/CA2564368A1/en not_active Abandoned
-
2006
- 2006-10-26 IL IL178870A patent/IL178870A0/en unknown
- 2006-11-17 ZA ZA200609596A patent/ZA200609596B/en unknown
- 2006-11-28 NO NO20065485A patent/NO20065485L/no not_active Application Discontinuation
-
2011
- 2011-02-22 US US13/032,548 patent/US20110144323A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1742960A2 (en) | 2007-01-17 |
RU2006141389A (ru) | 2008-06-10 |
CA2564368A1 (en) | 2005-11-10 |
CN101076539A (zh) | 2007-11-21 |
WO2005105825A3 (en) | 2006-02-23 |
KR20070028387A (ko) | 2007-03-12 |
US20110144323A1 (en) | 2011-06-16 |
EP2402362A2 (en) | 2012-01-04 |
JP2007534736A (ja) | 2007-11-29 |
WO2005105825A2 (en) | 2005-11-10 |
ZA200609596B (en) | 2008-01-30 |
GB0409567D0 (en) | 2004-06-02 |
SG155165A1 (en) | 2009-09-30 |
IL178870A0 (en) | 2007-03-08 |
US20080004249A1 (en) | 2008-01-03 |
AU2005238274A1 (en) | 2005-11-10 |
CN102516352A (zh) | 2012-06-27 |
MXPA06012641A (es) | 2006-12-15 |
TW200538145A (en) | 2005-12-01 |
BRPI0510458A (pt) | 2007-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20054905D0 (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
NO20055686L (no) | Sammensetning, fremgangsmate til fremstilling derav, og anvendelse derav. | |
IL233634A0 (en) | Methods, compositions and kits for treating medical conditions | |
WO2005105785A3 (en) | Indole derivatives for treatment of obesity | |
NO20071549L (no) | Nye benzofuserte heteroalrylsulfamidderivater, anvendelige som anti-krampemidler | |
NO20055204D0 (no) | Derivater av piperidinyl- og pipemzinylalkylkarbamater, fremgangsmater for fremstilling derav og anvendelse av de samme i terapi | |
IS7881A (is) | CHK-, PDK- og AKT-hindrandi pýrimidín, framleiðsla þeirra og notkun sem lyfjaefni | |
NO20051503D0 (no) | Pyrazolopyridiner og fremgangsmater for fremstilling og anvendelse av de samme. | |
NO20080010L (no) | GPCR-agonister | |
ZA200804079B (en) | Parthenogenic activation of human oocytes for the production of human embroyonic stem cells | |
NO20082170L (no) | Forbedret testosterongel og fremgangsmate til anvendelse | |
NO20055741L (no) | Nye kjemiske forbindelser | |
DK1670458T3 (da) | 1-Amino-2-oxy-substituerede tetrahydronaphthalenderivater, fremgangsmåder til fremstilling deraf og deres anvendelse som antiphlogistika | |
PT1893224T (pt) | Utilização de uma membrana de célula vegetal para o tratamento da obesidade | |
DK1718340T3 (da) | Nye effektorkonjugater, fremgangsmåde til deres fremstilling og deres farmaceutiske anvendelse | |
NO20064715L (no) | Deteksjon, isolering og anvendelse av renalase (monoamin aksidase C) | |
DE602005006105D1 (de) | Membrankörper und entsprechendes herstellungsverfahren | |
NO20074780L (no) | Heterocyklylamidsubstituerte imidazoler | |
ATE383384T1 (de) | Selbstemulgierende wässrige polyurethandispersionen | |
DK1727805T3 (da) | 1-phenyl- og 1-pyridylpyrazolderivater og anvendelse deraf som pesticider | |
NO20080034L (no) | Benzotiazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
NO20092134L (no) | Kombinasjonsprodukt for bruk i behandling av inflammatoriske lidelser | |
NO20072794L (no) | Kjemiske forbindelser | |
NO20082838L (no) | 9-klor-15-deoksyprostaglandinderivater, fremgangsmate for fremstilling av disse, og anvendelse som medikamenter | |
NO20065485L (no) | Kjemiske forbindelser |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |